
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
KaloCyte, Inc., a preclinical biotech that has developed an artificial RBC substitute for use as a lifeline when blood is not available. We are located at the University of Maryland, Baltimore (UMB) as an Affiliate of the UM BioPark. KaloCytes offices and labs are sited within the UM School of Medicines Center for Blood Oxygen Transport and Hemostasis (CBOTH) directed by Allan Doctor, MD (KaloCyte Co-Founder and CSO). KaloCyte was founded in 2016 by a distinguished team of Washington University in St. Louis researchers in physiology, bioengineering, and trauma care, with support from the BioGenerator Fundamentals program. KaloCyte has demonstrated...
Biotechnology,nanotechnology,startup,trauma care,rbc physiology,nanomedicine,transfusion medicine,blood substitutes,lipid nanoparticles,hemoglobin,lyophilization,and non-dilutive grant funding
Kalocyte, inc operates in the Biotechnology research industry.
Kalocyte, inc's revenue is 11m - 100m
Kalocyte, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.